Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Anika Therapeutics stock
Learn how to easily invest in Anika Therapeutics stock.
Anika Therapeutics Inc is a medical devices business based in the US. Anika Therapeutics shares (ANIK) are listed on the NASDAQ and all prices are listed in US Dollars. Anika Therapeutics employs 297 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Anika Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANIK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Anika Therapeutics stock price (NASDAQ: ANIK)Use our graph to track the performance of ANIK stocks over time.
Anika Therapeutics shares at a glance
|Latest market close||$22.51|
|52-week range||$19.95 - $45.81|
|50-day moving average||$21.93|
|200-day moving average||$31.92|
|Wall St. target price||$37.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.12|
Buy Anika Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Anika Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Anika Therapeutics price performance over time
|1 week (2022-06-24)||-0.09%|
|1 month (2022-05-28)||N/A|
|3 months (2022-03-29)||-13.72%|
|6 months (2021-12-31)||-37.18%|
|1 year (2021-07-01)||-49.38%|
|2 years (2020-07-01)||-41.64%|
|3 years (2019-07-01)||40.47|
|5 years (2017-06-30)||49.34|
Is Anika Therapeutics stock undervalued or overvalued?
Valuing Anika Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Anika Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Anika Therapeutics's PEG ratio
Anika Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1868. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Anika Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Anika Therapeutics's EBITDA
Anika Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.9 million.
The EBITDA is a measure of a Anika Therapeutics's overall financial performance and is widely used to measure a its profitability.
Anika Therapeutics financials
|Revenue TTM||$150.2 million|
|Gross profit TTM||$91.9 million|
|Return on assets TTM||-2.05%|
|Return on equity TTM||-0.58%|
|Market capitalisation||$327.7 million|
TTM: trailing 12 months
Anika Therapeutics share dividends
We're not expecting Anika Therapeutics to pay a dividend over the next 12 months.
Anika Therapeutics share price volatility
Over the last 12 months, Anika Therapeutics's shares have ranged in value from as little as $19.95 up to $45.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anika Therapeutics's is 1.1107. This would suggest that Anika Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Anika Therapeutics overview
Anika Therapeutics, Inc. , a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Anika Therapeutics in the news
Sidoti's Summer Small Cap Virtual Conference
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
Frequently asked questionsWhat percentage of Anika Therapeutics is owned by insiders or institutions?
Currently 1.916% of Anika Therapeutics shares are held by insiders and 89.886% by institutions. How many people work for Anika Therapeutics?
Latest data suggests 297 work at Anika Therapeutics. When does the fiscal year end for Anika Therapeutics?
Anika Therapeutics's fiscal year ends in December. Where is Anika Therapeutics based?
Anika Therapeutics's address is: 32 Wiggins Avenue, Bedford, MA, United States, 01730 What is Anika Therapeutics's ISIN number?
Anika Therapeutics's international securities identification number is: US0352551081 What is Anika Therapeutics's CUSIP number?
Anika Therapeutics's Committee on Uniform Securities Identification Procedures number is: 035255108
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert